Posted by Michael Wonder on 07 Apr 2022
A radical treatment for insulin pricing
6 April 2022 - A private, non-profit company recently announced that it intends to bypass the traditional supply chain and sell interchangeable biosimilar insulin products at substantially reduced prices.
